The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
The spliceosome as a target of novel antitumour drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Expansion of the eukaryotic proteome by alternative splicing
Nilsen, T. W., & Graveley, B. R. (2010) · Nature · doi:10.1038/nature08909 · Cited by 2,197
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Spliceosome Structure and Function
Will, C. L., & Luhrmann, R. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003707 · Cited by 1,829
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Chen, M., & Manley, J. L. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2777 · Cited by 1,284
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Alternative Splicing: New Insights from Global Analyses
Blencowe, B. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.023 · Cited by 1,130
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Wang, Z., & Burge, C. B. (2008) · RNA · doi:10.1261/rna.876308 · Cited by 1,086
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Whole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
Barash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J., & Frey, B. J. (2010) · Nature · doi:10.1038/nature09000 · Cited by 895
Pre-mRNA Processing Reaches Back toTranscription and Ahead to Translation
Moore, M. J., & Proudfoot, N. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.001 · Cited by 846
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
Epigenetics in Alternative Pre-mRNA Splicing
Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., & Misteli, T. (2011) · Cell · doi:10.1016/j.cell.2010.11.056 · Cited by 796
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Mechanisms and Consequences of Alternative Polyadenylation
Di Giammartino, D. C., Nishida, K., & Manley, J. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.017 · Cited by 737
Functional consequences of developmentally regulated alternative splicing
Kalsotra, A., & Cooper, T. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3052 · Cited by 729
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.18 · Cited by 650
STRUCTURAL INSIGHTS INTO TRANSLATIONAL FIDELITY
Ogle, J. M., & Ramakrishnan, V. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.061903.155440 · Cited by 588
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 580
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
Malcovati, L., Papaemmanuil, E., Bowen, D. T., Boultwood, J., Della Porta, M. G., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 498
Thol, F., Kade, S., Schlarmann, C., Löffeld, P., Morgan, M., Krauter, J., Wlodarski, M. W., Kölking, B., Wichmann, M., Görlich, K., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399337 · Cited by 419
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Makishima, H., Visconte, V., Sakaguchi, H., Jankowska, A. M., Abu Kar, S., Jerez, A., Przychodzen, B., Bupathi, M., Guinta, K., Afable, M. G., et al. (2012) · Blood · doi:10.1182/blood-2011-12-399774 · Cited by 370
Rossi, D., Bruscaggin, A., Spina, V., Rasi, S., Khiabanian, H., Messina, M., Fangazio, M., Vaisitti, T., Monti, S., Chiaretti, S., et al. (2011) · Blood · doi:10.1182/blood-2011-08-373159 · Cited by 369
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins
Xing, Y., Xu, Y., Chen, Y., Jeffrey, P. D., Chao, Y., Lin, Z., Li, Z., Strack, S., Stock, J. B., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.09.025 · Cited by 334
Topological characteristics of helical repeat protein
Groves, M. R., & Barford, D. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80052-9 · Cited by 331
Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J.-I., Murray, M. V., Kimura, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314298200 · Cited by 308
A Potential Role for U2AF-SAP 155 Interactions in Recruiting U2 snRNP to the Branch Site
Gozani, O., Potashkin, J., & Reed, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4752 · Cited by 298
Understanding splicing regulation through RNA splicing maps
Witten, J. T., & Ule, J. (2011) · Trends in Genetics · doi:10.1016/j.tig.2010.12.001 · Cited by 282
Molecular Architecture of the Multiprotein Splicing Factor SF3b
Golas, M. M., Sander, B., Will, C. L., Lührmann, R., & Stark, H. (2003) · Science · doi:10.1126/science.1084155 · Cited by 275
Corrionero, A., Miñana, B., & Valcárcel, J. (2011) · Genes & Development · doi:10.1101/gad.2014311 · Cited by 263
Self-citationHe, H., Liyanarachchi, S., Akagi, K., Nagy, R., Li, J., Dietrich, R. C., Li, W., Sebastian, N., Wen, B., Xin, B., et al. (2011) · Science · doi:10.1126/science.1200587 · Cited by 261
Damm, F., Kosmider, O., Gelsi-Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della Valle, V., Couronné, L., Scourzic, L., Chesnais, V., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400994 · Cited by 231
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L. A., Herzenberg, L. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604616103 · Cited by 231
Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA
Edery, P., Marcaillou, C., Sahbatou, M., Labalme, A., Chastang, J., Touraine, R., Tubacher, E., Senni, F., Bober, M. B., Nampoothiri, S., et al. (2011) · Science · doi:10.1126/science.1202205 · Cited by 228
Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing
Mermoud, J. E., Cohen, P., & Lamond, A. I. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.20.5263 · Cited by 218
NAKAJIMA, H., HORI, Y., TERANO, H., OKUHARA, M., MANDA, T., MATSUMOTO, S., & SHIMOMURA, K. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1204 · Cited by 216
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
Visconte, V, Makishima, H., Jankowska, A., Szpurka, H., Traina, F., Jerez, A., O'Keefe, C., Rogers, H. J., Sekeres, M. A., Maciejewski, J. P., et al. (2012) · Leukemia · doi:10.1038/leu.2011.232 · Cited by 213
The In Vivo Kinetics of RNA Polymerase II Elongation during Co-Transcriptional Splicing
Brody, Y., Neufeld, N., Bieberstein, N., Causse, S. Z., Böhnlein, E.-M., Neugebauer, K. M., Darzacq, X., & Shav-Tal, Y. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000573 · Cited by 205
Patnaik, M. M., Lasho, T. L., Hodnefield, J. M., Knudson, R. A., Ketterling, R. P., Garcia-Manero, G., Steensma, D. P., Pardanani, A., Hanson, C. A., & Tefferi, A. (2012) · Blood · doi:10.1182/blood-2011-09-377994 · Cited by 202
The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
O'Brien, K., Matlin, A. J., Lowell, A. M., & Moore, M. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805556200 · Cited by 200
Kyburz, A., Friedlein, A., Langen, H., & Keller, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.037 · Cited by 197
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis
Wang, C., Chua, K., Seghezzi, W., Lees, E., Gozani, O., & Reed, R. (1998) · Genes & Development · doi:10.1101/gad.12.10.1409 · Cited by 187
MIZUI, Y., SAKAI, T., IWATA, M., UENAKA, T., OKAMOTO, K., SHIMIZU, H., YAMORI, T., YOSHIMATSU, K., & ASADA, M. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.188 · Cited by 185
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
Visconte, V., Rogers, H. J., Singh, J., Barnard, J., Bupathi, M., Traina, F., McMahon, J., Makishima, H., Szpurka, H., Jankowska, A., et al. (2012) · Blood · doi:10.1182/blood-2012-05-430876 · Cited by 179
Biological validation that SF3b is a target of the antitumor macrolide pladienolide
Yokoi, A., Kotake, Y., Takahashi, K., Kadowaki, T., Matsumoto, Y., Minoshima, Y., Sugi, N. H., Sagane, K., Hamaguchi, M., Iwata, M., et al. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08387.x · Cited by 177
NAKAJIMA, H., SATO, B., FUJITA, T., TAKASE, S., TERANO, H., & OKUHARA, M. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1196 · Cited by 174
Warkocki, Z., Odenwälder, P., Schmitzová, J., Platzmann, F., Stark, H., Urlaub, H., Ficner, R., Fabrizio, P., & Lührmann, R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1729 · Cited by 172
Coupling Transcription and Alternative Splicing
Kornblihtt, A. R. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-77374-2_11 · Cited by 167
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Fan, L., Lagisetti, C., Edwards, C. C., Webb, T. R., & Potter, P. M. (2011) · ACS Chemical Biology · doi:10.1021/cb100356k · Cited by 167
Folco, E. G., Coil, K. E., & Reed, R. (2011) · Genes & Development · doi:10.1101/gad.2009411 · Cited by 162
Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing
Lardelli, R. M., Thompson, J. X., Yates, J. R., & Stevens, S. W. (2010) · RNA · doi:10.1261/rna.2030510 · Cited by 161
Stoilov, P., Lin, C.-H., Damoiseaux, R. D., Nikolic, J. M., & Black, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801661105 · Cited by 160
Wu, S., Kuo, Y., Hou, H., Li, L.-Y., Tseng, M., Huang, C., Lee, F., Liu, M.-C., Liu, C., Lin, C., et al. (2012) · Blood · doi:10.1182/blood-2012-02-412296 · Cited by 158
Identification of SAP155 as the Target of GEX1A (Herboxidiene), an Antitumor Natural Product
Hasegawa, M., Miura, T., Kuzuya, K., Inoue, A., Ki, S. W., Horinouchi, S., Yoshida, T., Kunoh, T., Koseki, K., Mino, K., et al. (2010) · ACS Chemical Biology · doi:10.1021/cb100248e · Cited by 153
Ml, Z., Lorson, C., Androphy, E. J., & Zhou, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301550 · Cited by 140
Myeloid malignancies: mutations, models and management
Murati, A., Brecqueville, M., Devillier, R., Mozziconacci, M.-J., Gelsi-Boyer, V., & Birnbaum, D. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-304 · Cited by 139
Younis, I., Berg, M. G., Kaida, D., Dittmar, K. A., Wang, C., & Dreyfuss, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01301-09 · Cited by 138
SAKAI, T., Sameshima, T., Matsufuji, M., Kawamura, N., Dobashi, K., & Mizui, Y. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.173 · Cited by 131
Pilch, B., Allemand, E., Facompré, M., et al. (2001) · PubMed · Cited by 130
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation
Roybal, G. A., & Jurica, M. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq494 · Cited by 126
Yoon, S.-O., Shin, S., Lee, H.-J., Chun, H., & Chung, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0321 · Cited by 126
Soret, J., Bakkour, N., Maire, S., Durand, S., Zekri, L., Gabut, M., Fic, W., Divita, G., Rivalle, C., Dauzonne, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409829102 · Cited by 124
Schmidt, U., Basyuk, E. I., Robert, M.-C., Yoshida, M., Villemin, J.-P., Auboeuf, D., Aitken, S., & Bertrand, É. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201009012 · Cited by 121
Lasho, T. L., Finke, C. M., Hanson, C. A., Jimma, T., Knudson, R. A., Ketterling, R. P., Pardanani, A. D., & Tefferi, A. (2011) · Leukemia · doi:10.1038/leu.2011.320 · Cited by 117
Visconte, V., Makishima, H., Maciejewski, J. P., & Tiu, R. V. (2012) · Leukemia · doi:10.1038/leu.2012.130 · Cited by 115
Isono, K., Mizutani-Koseki, Y., Komori, T., Schmidt-Zachmann, M. S., & Koseki, H. (2005) · Genes & Development · doi:10.1101/gad.1284605 · Cited by 110
Roca, X., Akerman, M., Gaus, H. J., Berdeja, A., Bennett, C. F., & Krainer, A. R. (2012) · Genes & Development · doi:10.1101/gad.190173.112 · Cited by 110
Albert, B. J., McPherson, P. A., O'Brien, K., Czaicki, N. L., DeStefino, V. J., Osman, S., Li, M., Day, B. W., Grabowski, P. J., Moore, M. J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0051 · Cited by 99
Webb, T. R., Joyner, A. S., & Potter, P. M. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.013 · Cited by 99
p53 is activated in response to disruption of the pre-mRNA splicing machinery
Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J., & Saville, M. K. (2012) · Oncogene · doi:10.1038/onc.2012.38 · Cited by 98
Molecular Pathophysiology of Myelodysplastic Syndromes
Lindsley, R. C., & Ebert, B. L. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132436 · Cited by 88
Massiello, A., Roesser, J. R., Chalfant, C. E., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5021fje · Cited by 88
Invariant U2 snRNA Nucleotides Form a Stem Loop to Recognize the Intron Early in Splicing
Perriman, R., & Ares, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.036 · Cited by 86
DEGRADE, MOVE, REGROUP: signaling control of splicing proteins
Heyd, F., & Lynch, K. W. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.04.003 · Cited by 82
Golas, M. M., Sander, B. O., Will, C. L., Lührmann, R., & Stark, H. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.016 · Cited by 82
Spliceosome assembly is coupled to RNA polymerase II dynamics at the 3′ end of human genes
Martins, S., Rino, J., Carvalho, T., Carvalho, C., Yoshida, M., Klose, J. M., de Almeida, S. F., & Carmo‐Fonseca, M. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2124 · Cited by 81
Structural Requirements for the Antiproliferative Activity of Pre‐mRNA Splicing Inhibitor FR901464
Osman, S., Albert, B. J., Wang, Y., Li, M., Czaicki, N. L., & Koide, K. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201002402 · Cited by 78
Hirabayashi, S., Flotho, C., Moetter, J., Heuser, M., Hasle, H., Gruhn, B., Klingebiel, T. E., Thol, F. R., Schlegelberger, B., Baumann, I., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395087 · Cited by 71
Splicing in oncogenesis and tumor suppression
Kaida, D., Schneider‐Poetsch, T., & Yoshida, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02356.x · Cited by 71
Ghigna, C., de Toledo, M., Bonomi, S., Valacca, C., Gallo, S., Apicella, M., Eperon, I. C., Tazi, J., & Biamonti, G. (2010) · RNA Biology · doi:10.4161/rna.7.4.12744 · Cited by 70
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Shkreta, L., Froehlich, U., Paquet, É. R., Toutant, J., Elela, S. A., & Chabot, B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0192 · Cited by 69
Antitumor Compounds Based on a Natural Product Consensus Pharmacophore
Lagisetti, C., Pourpak, A., Jiang, Q. L., Cui, X., Goronga, T., Morris, S. W., & Webb, T. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006195 · Cited by 69
Anderson, E. S., Lin, C.-H., Xiao, X. G., Stoilov, P., Burge, C. B., & Black, D. L. (2012) · RNA · doi:10.1261/rna.032912.112 · Cited by 69
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
Furumai, R., Uchida, K., Komi, Y., Yoneyama, M., Ishigami, K., Watanabe, H., Kojima, S., & Yoshida, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01686.x · Cited by 66
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 63
Chang, W., Liu, T., Yang, W.-K., Lee, C.-C., Lin, Y., Chen, T., & Chang, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1037 · Cited by 61
Spliceosome mutations in hematopoietic malignancies
Hahn, C. N., & Scott, H. S. (2011) · Nature Genetics · doi:10.1038/ng.1045 · Cited by 59
U2 snRNP Binds Intronless Histone Pre-mRNAs to Facilitate U7-snRNP-Dependent 3′ End Formation
Friend, K., Lovejoy, A. F., & STEITZ, J. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.026 · Cited by 57
Jeromin, S., Haferlach, T., Großmann, V., Alpermann, T., Kowarsch, A., Haferlach, C., Kern, W., & Schnittger, S. (2012) · Haematologica · doi:10.3324/haematol.2012.072538 · Cited by 55
Alternative splicing interference by xenobiotics
Zaharieva, E. E., Chipman, J. K., & Soller, M. (2012) · Toxicology · doi:10.1016/j.tox.2012.01.014 · Cited by 55
Chronic Lymphocytic Leukemia withSF3B1Mutation
Quesada, V., Ramsay, A. J., & López-Otı́n, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1204033 · Cited by 53
Proofreading and spellchecking: A two-tier strategy for pre-mRNA splicing quality control
Egecioglu, D. E., & Chanfreau, G. (2011) · RNA · doi:10.1261/rna.2454711 · Cited by 49
Heterogeneity in mammalian RNA 3′ end formation
Neilson, J. R., & Sandberg, R. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.040 · Cited by 45
The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
Abdel-Wahab, O. I., & Levine, R. L. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.004 · Cited by 43
Smith, D. J., Konarska, M. M., & Query, C. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.012 · Cited by 43
Berg, M. G., Wan, L., Younis, I., Diem, M. D., Soo, M., Wang, C., & Dreyfuss, G. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05788-11 · Cited by 40
An, M. J., & Henion, P. D. (2012) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113383ma · Cited by 36
Cui, R., Gale, R. P., Xu, Z., Qin, T., Fang, L., Zhang, H., Pan, L., Zhang, Y., & Xiao, Z. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.08.015 · Cited by 33
Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies
Damm, F., Nguyen‐Khac, F., Fontenay, M., & Bernard, O. (2012) · Leukemia · doi:10.1038/leu.2012.86 · Cited by 32
Probing Interactions between the U2 Small Nuclear Ribonucleoprotein and the DEAD-box Protein, Prp5
Dayyeh, B. K. A., Quan, T. K., Castro, M., & Ruby, S. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109553200 · Cited by 32
MDM2 and MDM4 splicing: an integral part of the cancer spliceome
Jeyaraj, S. C. (2009) · Frontiers in bioscience · doi:10.2741/3402 · Cited by 31
Zhang, Z., Kelemen, O., van Santen, M. A., Yelton, S. M., Wendlandt, A. E., Sviripa, V. M., Bollen, M., Beullens, M., Urlaub, H., Lührmann, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183970 · Cited by 25
Cited by
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Lee, Y., & Rio, D. C. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034316 · Cited by 1,291
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
Bueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Self-citation
Metadata
- Authors
- Bonnal, S., Vigevani, L., & Valcárcel, J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-11
- Volume
- 11
- Issue
- 11
- Pages
- 847-859
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2151873427
- Cited by
- 405
- References
- 113
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.